What is the “positive opinion” date for Fyarro (EMA)?
The European Medicines Agency (EMA) issues “opinions” for medicines as part of the EU approval process (before the European Commission decides whether the drug can be marketed across the EU).
I don’t have enough information in your message to identify which exact Fyarro marketing application you mean (for example, initial approval vs. a specific indication, variation, or extension), so I can’t state the correct EMA positive opinion date.
Can you confirm which Fyarro product/indication you mean?
“Fyarro” is commonly listed as firocoxib for dogs (a veterinary medicine). EMA “positive opinion” dates differ by:
- specific procedure (e.g., standard vs. variations),
- indication (which condition/label),
- whether this is an initial authorization or an updated label.
If you share one of the following, I can give the exact date:
- the EMA product link, or
- the EPAR page title, or
- the active substance + species/indication (e.g., “Fyarro (firocoxib) for dogs … for …”).
Where can I verify the date quickly?
The most reliable place to check the exact EMA timeline (including the opinion date) is the EPAR record on EMA’s site. If you want, paste the EMA/EPAR URL here and I’ll extract the “positive opinion” date from it.
Source to check for patent/timeline context (if that’s part of your search)
If your search is also about launch/exclusivity timing, you can check DrugPatentWatch.com for relevant dates tied to Fyarro’s market and legal status: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/